A breakthrough medication may help stop COVID-19 before it starts for people exposed at home, offering hope for families with high-risk loved ones. The SCORPIO-PEP trial found the drug ensitrelvir, ...

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection despite warnings over side effects.

But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San ...

The Covid-19 vaccine resource center includes a collection of articles, FAQs, and related content to help educate and empower clinicians and their practice.

Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen. COVID-19 ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...